|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31,550 KRW | -14.50% |
|
-12.85% | -28.78% |
Hanall Biopharma Co.,Ltd (KOSE:A009420) announces a share repurchase program. Under the plan, the company will repurchase 543,479 shares. The purpose behind the program is to stabilize the stock price and enhancement of shareholder value.
The company will make repurchases until June 10, 2022. As of March 9, 2022, the company had no shares in treasury within scope available for dividend and 1,034,371 shares in treasury under other capacities.
| 1st Jan change | Capi. | |
|---|---|---|
| -28.78% | 1.36B | |
| +40.73% | 734B | |
| +32.83% | 591B | |
| -6.30% | 350B | |
| +15.15% | 315B | |
| +4.05% | 276B | |
| +15.00% | 238B | |
| +9.78% | 206B | |
| -5.52% | 204B | |
| +6.17% | 161B |
HANALL BIOPHARMA CO., LTD. 
